Current Report · Items 5.07, 9.01 · 8-K

MIRA Pharmaceuticals, Inc.

MIRANASDAQEQUITYCurrent

Submission of Matters to a Vote of Security Holders

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Description No. ────────────────────────────────────────────────────────────────────── 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Filed Sep 16, 2026Accepted Sep 16, 2026, 4:30 PM EDTCIK 1904286Accession 0001493152-26-042927

View company →Permanent SEC source ↗

Company context

Current securities

MIRANASDAQ · EQUITY · Current

Recent company filings

Registered securities in this filing

MIRA PHARMACEUTICALS, INC. · 8-K · Filed 2026-09-16

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, $0.0001 par value per share

Symbol: MIRA
Exchange: NASDAQ
Classification: COMMON
Status: Current

Filing context

Context: AsOf2026-09-11

Dimensions: Not supplied

Accession 000149315226042927 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 5.07, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 9.01Item 9.01 - Financial Statements and Exhibits

Get the free weekly BCS email.